Compound Heterozygous Mutations in the Hairless Gene in Atrichia with Papular Lesions

    Amy S. Paller, George Varigos, Arye Metzker, Robert C. Bauer, Jacinta Opie, Amalia Martı́nez-Mir, Angela M. Christiano, Abraham Zlotogorski
    TLDR Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.
    The study identified compound heterozygous mutations in the hairless (HR) gene in three individuals from nonconsanguineous families, leading to atrichia with papular lesions (APL), a condition often misdiagnosed as alopecia universalis (AU). The research highlighted the importance of distinguishing between APL and AU, as APL did not respond to treatments effective for AU. The study found recurrent mutations, such as the nonsense mutation Q478X and the missense mutation C622G, suggesting these might have been mutational hotspots. The findings suggested that APL might have been more common than previously thought, especially in nonconsanguineous families, and recommended genetic testing for HR mutations in infants with presumed AU before starting ineffective treatments.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 1000+ results

      community Minoxidil is a 5ar inhibitor according to research

      in Research/Science  148 upvotes 2 months ago
      Minoxidil may inhibit androgen receptors and affect hormonal pathways, potentially explaining its effectiveness in treating androgenetic alopecia (AGA). Users discuss its varying effectiveness on scalp versus facial hair and note fewer side effects with topical use compared to oral.

      community Great news recently for people with hairloss!

      in Research/Science  113 upvotes 8 months ago
      A potential treatment for alopecia involving a protein that calms hair follicles has shown promise in rats, but skepticism remains about its applicability to humans. Many users express doubt about the timeline for effective hair loss treatments, comparing it to past unfulfilled promises.

      community Testosterone in Reference Range Doesn't Cause Hair Loss

      in Research/Science  50 upvotes 1 year ago
      Testosterone within the normal range does not significantly contribute to male pattern baldness (MPB); DHT is the main factor that can be controlled. Genetics play a crucial role in hair loss, and treatments like finasteride and dutasteride, which block DHT, can help despite potentially raising testosterone levels.

      community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

      in Research/Science  121 upvotes 2 years ago
      The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

      community What would hair loss treatment be like in the 2030s?

      in Treatment  5 upvotes 1 year ago
      The conversation discusses future hair loss treatments, with mentions of dutasteride potentially gaining FDA approval and increased popularity. Skepticism remains about significant advancements due to limited funding and reliance on cosmetic companies.

    Related Research

    4 / 4 results